CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Mylan Pharmaceuticals Inc. et al. vs. Regeneron Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2023-00099 filed by Mylan Pharmaceuticals Inc. et al. on 2022-10-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00099

Filing Date

2022-10-28

Accorded Filing Date

2022-10-28

Institution Decision Date

2023-03-01

Last Modified Date

2024-10-01

Proceeding Type

IPR

Termination Date

2023-03-01

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 16055847
Respondent Patent Number 10857205
Legal Expiration Date
2038-08-06 Active (11.7 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor George D. Yancopoulos
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Board Decisions & Rulings (1)

Institution Denied 2023-03-01
Decision Denying Institution of Inter Partes Review
37 CFR 42.107, 35 USC 314

Address and Attorney/Agent Information

23 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name A&P - Regeneron (Prosecution)
Customer Number 191459
Address 601 Massachusetts Ave., NW, Washington, DC, 20001-3743, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
41408 David Marsh +1 202-942-5068
48001 Thomas Triolo +1 914-847-1612
48921 Stephen Gaudet +1 914-847-7376
50370 Neil Miyamoto +1 914-847-7175
50437 Frank Cottingham +1 914-593-1116
58583 Brian Cocca +1 914-847-1421
58714 Ilona Gont +1 914-847-1304
59668 Brandon Schurter +1 914-847-7000

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 14 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 7 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (14): ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (7 found):
PTAB: 7
USPTO PTAB Trial 2023-12-18
IPR2024-00298

Biocon Biologics Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-12-14
IPR2024-00260

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-04-27
IPR2023-00884

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Terminated-Adverse Judgment
USPTO PTAB Trial 2023-02-10
IPR2023-00532

Celltrion, Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10130681)
Status: Final Written Decision
USPTO PTAB Trial 2023-01-06
IPR2023-00442

Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10130681)
Status: Final Written Decision
USPTO PTAB Trial 2022-09-09
IPR2022-01524

Apotex Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (11253572)
Status: Institution Denied
USPTO PTAB Trial 2022-07-01
IPR2022-01225

Mylan Pharmaceuticals Inc. et al. v. Regeneron Pharmaceuticals, Inc.

U.S. Continuation Sibling (10130681)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

107
12

Notice: refund approved NOTICE

2024-10-01 FILING PARTY: BOARD
11

Petitioner's Request for Refund OTHER

2024-09-24 FILING PARTY: PETITIONER
10

Decision Denying Institution of Inter Partes Review DECISION

2023-03-01 FILING PARTY: BOARD
3001

Email Exhibit

2023-03-01 FILING PARTY: BOARD
2001

Exhibit 2001 Exhibit

2023-02-23 FILING PARTY: PATENT OWNER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc